00I

N-[(1R)-1-(4-carbamimidoylbenzyl)-2-oxo-2-piperidin-1-ylethyl]-N~2~-(naphthalen-2-ylsulfonyl)-L-alpha-glutamine

Created:	2010-10-19
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where 00I is found in a polymer sequence

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	77
Chiral Atom Count	2
Bond Count	80
Aromatic Bond Count	17

2D diagram of 00I

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[(1R)-1-(4-carbamimidoylbenzyl)-2-oxo-2-piperidin-1-ylethyl]-N~2~-(naphthalen-2-ylsulfonyl)-L-alpha-glutamine
Systematic Name (OpenEye OEToolkits)	(4S)-5-[[(2R)-3-(4-carbamimidoylphenyl)-1-oxo-1-piperidin-1-yl-propan-2-yl]amino]-4-(naphthalen-2-ylsulfonylamino)-5-oxo-pentanoic acid
Formula	C₃₀ H₃₅ N₅ O₆ S
Molecular Weight	593.694
Type	PEPTIDE-LIKE

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(N1CCCCC1)C(NC(=O)C(NS(=O)(=O)c3cc2ccccc2cc3)CCC(=O)O)Cc4ccc(C(=[N@H])N)cc4
SMILES	CACTVS	3.370	NC(=N)c1ccc(C[CH](NC(=O)[CH](CCC(O)=O)N[S](=O)(=O)c2ccc3ccccc3c2)C(=O)N4CCCCC4)cc1
SMILES	OpenEye OEToolkits	1.7.0	c1ccc2cc(ccc2c1)S(=O)(=O)NC(CCC(=O)O)C(=O)NC(Cc3ccc(cc3)C(=N)N)C(=O)N4CCCCC4
Canonical SMILES	CACTVS	3.370	NC(=N)c1ccc(C[C@@H](NC(=O)[C@H](CCC(O)=O)N[S](=O)(=O)c2ccc3ccccc3c2)C(=O)N4CCCCC4)cc1
Canonical SMILES	OpenEye OEToolkits	1.7.0	[H]/N=C(\c1ccc(cc1)C[C@H](C(=O)N2CCCCC2)NC(=O)[C@H](CCC(=O)O)NS(=O)(=O)c3ccc4ccccc4c3)/N
InChI	InChI	1.03	InChI=1S/C30H35N5O6S/c31-28(32)22-10-8-20(9-11-22)18-26(30(39)35-16-4-1-5-17-35)33-29(38)25(14-15-27(36)37)34-42(40,41)24-13-12-21-6-2-3-7-23(21)19-24/h2-3,6-13,19,25-26,34H,1,4-5,14-18H2,(H3,31,32)(H,33,38)(H,36,37)/t25-,26+/m0/s1
InChIKey	InChI	1.03	XRFHGJLVHMSQFX-IZZNHLLZSA-N

Related Resource References

Resource Name	Reference
PubChem	137347827

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.